FY2026 EPS Estimates for Quantum-Si Lifted by HC Wainwright

Key Points

• HC Wainwright raised Quantum-Si’s FY2026 EPS estimate to a loss of $0.47 per share from a previous loss estimate of $0.49, while forecasting continued losses through FY2029 before projecting $0.03 EPS in FY2030.
• Quantum-Si’s latest quarterly results matched expectations at a loss of $0.11 per share, while revenue of $0.34 million exceeded the $0.30 million consensus estimate.
• QSI shares opened at $0.74, near their 52-week low of $0.69. Analyst sentiment remains mixed, with a consensus “Hold” rating and a $1.00 target price; institutional investors own 39.9% of the stock.

Quantum-Si Incorporated (NASDAQ:QSI - Free Report) - Investment analysts at HC Wainwright upped their FY2026 earnings estimates for Quantum-Si in a research report issued to clients and investors on Friday, August 14th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.47) per share for the year, up from their previous forecast of ($0.49). The consensus estimate for Quantum-Si's current full-year earnings is ($0.49) per share. HC Wainwright also issued estimates for Quantum-Si's Q4 2026 earnings at ($0.13) EPS, Q2 2027 earnings at ($0.11) EPS, Q3 2027 earnings at ($0.10) EPS, Q4 2027 earnings at ($0.09) EPS, FY2027 earnings at ($0.42) EPS, FY2028 earnings at ($0.27) EPS, FY2029 earnings at ($0.15) EPS and FY2030 earnings at $0.03 EPS.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The business had revenue of $0.34 million during the quarter, compared to analysts' expectations of $0.30 million.

Several other analysts also recently commented on the company. Weiss Ratings downgraded Quantum-Si from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Tuesday, August 11th. Alliance Global Partners reaffirmed a "buy" rating on shares of Quantum-Si in a research note on Friday. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Quantum-Si has a consensus rating of "Hold" and a consensus target price of $1.00.

Quantum-Si Price Performance

QSI stock opened at $0.74 on Tuesday. The stock has a market capitalization of $162.06 million, a PE ratio of -1.62 and a beta of 3.24. The company's 50-day moving average is $0.86 and its 200-day moving average is $0.92. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $3.10.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Millennium Management LLC bought a new position in shares of Quantum-Si in the first quarter valued at $4,721,000. State Street Corp increased its position in shares of Quantum-Si by 26.5% during the fourth quarter. State Street Corp now owns 3,562,721 shares of the company's stock worth $3,919,000 after acquiring an additional 745,231 shares in the last quarter. Squarepoint Ops LLC purchased a new stake in shares of Quantum-Si in the third quarter worth approximately $865,000. Bank of America Corp DE boosted its position in shares of Quantum-Si by 426.6% during the second quarter. Bank of America Corp DE now owns 465,999 shares of the company's stock valued at $913,000 after buying an additional 377,504 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Quantum-Si by 9.8% during the fourth quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company's stock valued at $4,527,000 after buying an additional 367,206 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company's stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source